Fort Worth, TX, United States of America

Thomas A Callaghan

This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Alcon, Inc., Novartis Ag. Active years: 2004-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas A Callaghan. Retrieved from https://idiyas.com/inventor/thomas-a-callaghan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2004-2023

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Thomas A. Callaghan

Introduction

Thomas A. Callaghan is a notable inventor based in Fort Worth, Texas, recognized for his significant contributions to the field of intraocular lens technology. With a total of six patents to his name, Callaghan has made strides in developing advanced materials and compositions that enhance the performance of intraocular lenses.

Latest Patents

Among his latest innovations are novel intraocular lens compositions that utilize a hydroxyl functional acrylic monomer. These compositions are designed to possess a high Abbe number, which minimizes optical distortions, and exhibit minimal glistenings. Additionally, they demonstrate suitable mechanical properties for small incision delivery, making them highly beneficial for surgical applications.

Career Highlights

Throughout his career, Thomas A. Callaghan has worked with prominent companies in the medical field, including Alcon, Inc. and Novartis AG. His experience in these organizations has allowed him to refine his expertise and contribute to the advancement of ocular health technologies.

Collaborations

Callaghan has collaborated with esteemed colleagues such as Albert R. LeBoeuf and Xuwei Jiang, further enhancing the innovative potential of his projects. Their combined efforts have led to significant advancements in the field of intraocular lens development.

Conclusion

In summary, Thomas A. Callaghan's work in the realm of intraocular lens compositions showcases his dedication to innovation and improvement in medical technology. His contributions continue to impact the field positively, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…